ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

0J7G Hutchison China Meditech Ltd

33.29
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hutchison China Meditech Ltd LSE:0J7G London Ordinary Share HUTCHISON CHINA MEDITECH ADR REPRESENTIN
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 33.29 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 838M 100.78M - N/A 0

Hutchmed (China) Limited Vesting of awards under the LTIP (5723D)

21/10/2022 9:30am

UK Regulatory


Hutchison China Meditech (LSE:0J7G)
Historical Stock Chart


From Apr 2022 to Apr 2024

Click Here for more Hutchison China Meditech Charts.

TIDMHCM

RNS Number : 5723D

Hutchmed (China) Limited

21 October 2022

Vesting of awards under the Long Term Incentive Plan

Hong Kong, Shanghai & Florham Park, NJ - Friday, October 21, 2022: HUTCHMED (China) Limited (" HUTCHMED ") (Nasdaq/AIM: HCM; SEHK:13) announces that the non-performance based awards granted under the Long Term Incentive Plan ("LTIP") on October 20, 2021 to the following persons discharging managerial responsibilities were vested on October 20, 2022:

 
                                                 Number of American depositary 
Award Holder                                      shares ("ADS") 
----------------------------------------------   ----------------------------- 
 
Mr Simon To (Executive Director)                 1,937 (1) 
Dr Dan Eldar (Non-executive Director ("NED"))    1,937 
Ms Edith Shih (NED)                              1,937 (2) 
Mr Paul Carter (Independent Non-executive 
 Director ("INED"))                              1,647 (3) 
Dr Karen Ferrante (INED)                         1,647 (4) 
Mr Graeme Jack (INED)                            1,937 
Professor Tony Mok (INED)                        1,937 
 

Notes:

(1) Similar to the arrangement for his Director's fees, these ADSs were not received by Mr Simon To, but were received by or for the account of his employer, Hutchison Whampoa (China) Limited.

(2) These ADSs were not received by Ms Edith Shih, but were received by or for the account of her employer, Hutchison International Limited.

(3) Mr Paul Carter elected, on acceptance of the grant of his awards, to have 15% of his LTIP awards (amounting to US$9,375 with respect to his awards which vested on October 20, 2022) held on his behalf by the trustee administering the LTIP pending vesting in the form of cash, to settle his tax liabilities in respect of his awards.

(4) Dr Karen Ferrante elected, on acceptance of the grant of her awards, to have 15% of her LTIP awards (amounting to US$9,375 with respect to her awards which vested on October 20, 2022) held on her behalf by the trustee administering the LTIP pending vesting in the form of cash, to settle her tax liabilities in respect of her awards.

The notifications set out below are provided in accordance with the requirements of the UK Market Abuse Regulation.

(a) Dr Dan Eldar

 
 1      Details of the person discharging managerial responsibilities/person closely associated 
 
   a)     Name                                                 Dr Dan Eldar 
       ---------------------------------------------------  ---------------------------------------- 
 2      Reason for the notification 
       --------------------------------------------------------------------------------------------- 
 
   a)     Position/status                                      Non-Executive Director 
       ---------------------------------------------------  ---------------------------------------- 
 
   b)     Initial notification/Amendment                       Initial notification 
       ---------------------------------------------------  ---------------------------------------- 
 3      Details of the issuer, emission allowance market participant, auction platform, auctioneer 
         or auction monitor 
       --------------------------------------------------------------------------------------------- 
 
   a)     Name                                                 HUTCHMED (China) Limited 
       ---------------------------------------------------  ---------------------------------------- 
 
   b)     LEI                                                  2138006X34YDQ6OBYE79 
       ---------------------------------------------------  ---------------------------------------- 
 
 
 4       Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
          each type of transaction; (iii) each date; and (iv) each place where transactions have been 
          conducted 
 
   a)     Description of the financial instrument, type of         ADS each representing five Ordinary Shares of 
          instrument                                               US$0.10 
 
          Identification code 
 
                                                                   ADS ISIN: US44842L1035 
        -------------------------------------------------------  ----------------------------------------------------- 
 
   b)      Nature of the transaction                               Vesting of awards granted on October 20, 2021 under 
                                                                   HUTCHMED's LTIP 
        -------------------------------------------------------  ----------------------------------------------------- 
                                                                    Price(s)   Volume(s) 
   c)      Price(s) and volume(s)                                    Nil        1,937 ADS 
                                                                               ---------- 
        -------------------------------------------------------  ----------------------------------------------------- 
 
   d)      Aggregated information                                   N/A 
           -  Aggregated volume 
           -  Price 
        -------------------------------------------------------  ----------------------------------------------------- 
 
   e)      Date of the transaction                                  2022-10-20 
        -------------------------------------------------------  ----------------------------------------------------- 
 
   f)      Place of the transaction                                 Outside a trading venue 
        -------------------------------------------------------  ----------------------------------------------------- 
 

(b) Mr Paul Carter

 
 1       Details of the person discharging managerial responsibilities/person closely associated 
 
   a)      Name                                                     Mr Paul Carter 
        -------------------------------------------------------  ----------------------------------------------------- 
 2       Reason for the notification 
        -------------------------------------------------------------------------------------------------------------- 
 
   a)      Position/status                                          Independent Non-Executive Director 
        -------------------------------------------------------  ----------------------------------------------------- 
 
   b)      Initial notification/Amendment                           Initial notification 
        -------------------------------------------------------  ----------------------------------------------------- 
 3       Details of the issuer, emission allowance market participant, auction platform, auctioneer 
          or auction monitor 
        -------------------------------------------------------------------------------------------------------------- 
 
   a)      Name                                                     HUTCHMED (China) Limited 
        -------------------------------------------------------  ----------------------------------------------------- 
 
   b)      LEI                                                      2138006X34YDQ6OBYE79 
        -------------------------------------------------------  ----------------------------------------------------- 
 4       Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
          each type of transaction; (iii) each date; and (iv) each place where transactions have been 
          conducted 
        -------------------------------------------------------------------------------------------------------------- 
 
   a)     Description of the financial instrument, type of         ADS each representing five Ordinary Shares of 
          instrument                                               US$0.10 
 
          Identification code 
 
                                                                   ADS ISIN: US44842L1035 
        -------------------------------------------------------  ----------------------------------------------------- 
 
   b)      Nature of the transaction                               Vesting of awards granted on October 20, 2021 under 
                                                                   HUTCHMED's LTIP 
        -------------------------------------------------------  ----------------------------------------------------- 
                                                                    Price(s)   Volume(s) 
   c)      Price(s) and volume(s)                                    Nil        1,647 ADS 
                                                                               ---------- 
        -------------------------------------------------------  ----------------------------------------------------- 
 
   d)      Aggregated information                                   N/A 
           -  Aggregated volume 
           -  Price 
        -------------------------------------------------------  ----------------------------------------------------- 
 
   e)      Date of the transaction                                  2022-10-20 
        -------------------------------------------------------  ----------------------------------------------------- 
 
   f)      Place of the transaction                                 Outside a trading venue 
        -------------------------------------------------------  ----------------------------------------------------- 
 

(c) Dr Karen Ferrante

 
 1       Details of the person discharging managerial responsibilities/person closely associated 
 
   a)      Name                                                     Dr Karen Ferrante 
        -------------------------------------------------------  ----------------------------------------------------- 
 2       Reason for the notification 
        -------------------------------------------------------------------------------------------------------------- 
 
   a)      Position/status                                          Independent Non-Executive Director 
        -------------------------------------------------------  ----------------------------------------------------- 
 
   b)      Initial notification/Amendment                           Initial notification 
        -------------------------------------------------------  ----------------------------------------------------- 
 3       Details of the issuer, emission allowance market participant, auction platform, auctioneer 
          or auction monitor 
        -------------------------------------------------------------------------------------------------------------- 
 
   a)      Name                                                     HUTCHMED (China) Limited 
        -------------------------------------------------------  ----------------------------------------------------- 
 
   b)      LEI                                                      2138006X34YDQ6OBYE79 
        -------------------------------------------------------  ----------------------------------------------------- 
 4       Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
          each type of transaction; (iii) each date; and (iv) each place where transactions have been 
          conducted 
        -------------------------------------------------------------------------------------------------------------- 
 
   a)     Description of the financial instrument, type of         ADS each representing five Ordinary Shares of 
          instrument                                               US$0.10 
 
          Identification code 
 
                                                                   ADS ISIN: US44842L1035 
        -------------------------------------------------------  ----------------------------------------------------- 
 
   b)      Nature of the transaction                               Vesting of awards granted on October 20, 2021 under 
                                                                   HUTCHMED's LTIP 
        -------------------------------------------------------  ----------------------------------------------------- 
                                                                    Price(s)   Volume(s) 
   c)      Price(s) and volume(s)                                    Nil        1,647 ADS 
                                                                               ---------- 
        -------------------------------------------------------  ----------------------------------------------------- 
 
   d)      Aggregated information                                   N/A 
           -  Aggregated volume 
           -  Price 
        -------------------------------------------------------  ----------------------------------------------------- 
 
   e)      Date of the transaction                                  2022-10-20 
        -------------------------------------------------------  ----------------------------------------------------- 
 
   f)      Place of the transaction                                 Outside a trading venue 
        -------------------------------------------------------  ----------------------------------------------------- 
 

(d) Mr Graeme Jack

 
 1       Details of the person discharging managerial responsibilities/person closely associated 
 
   a)      Name                                                     Mr Graeme Jack 
        -------------------------------------------------------  ----------------------------------------------------- 
 2       Reason for the notification 
        -------------------------------------------------------------------------------------------------------------- 
 
   a)      Position/status                                          Independent Non-Executive Director 
        -------------------------------------------------------  ----------------------------------------------------- 
 
   b)      Initial notification/Amendment                           Initial notification 
        -------------------------------------------------------  ----------------------------------------------------- 
 3       Details of the issuer, emission allowance market participant, auction platform, auctioneer 
          or auction monitor 
        -------------------------------------------------------------------------------------------------------------- 
 
   a)      Name                                                     HUTCHMED (China) Limited 
        -------------------------------------------------------  ----------------------------------------------------- 
 
   b)      LEI                                                      2138006X34YDQ6OBYE79 
        -------------------------------------------------------  ----------------------------------------------------- 
 4       Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
          each type of transaction; (iii) each date; and (iv) each place where transactions have been 
          conducted 
        -------------------------------------------------------------------------------------------------------------- 
 
   a)     Description of the financial instrument, type of         ADS each representing five Ordinary Shares of 
          instrument                                               US$0.10 
 
          Identification code 
 
                                                                   ADS ISIN: US44842L1035 
        -------------------------------------------------------  ----------------------------------------------------- 
 
   b)      Nature of the transaction                               Vesting of awards granted on October 20, 2021 under 
                                                                   HUTCHMED's LTIP 
        -------------------------------------------------------  ----------------------------------------------------- 
                                                                    Price(s)   Volume(s) 
   c)      Price(s) and volume(s)                                    Nil        1,937 ADS 
                                                                               ---------- 
        -------------------------------------------------------  ----------------------------------------------------- 
 
   d)      Aggregated information                                   N/A 
           -  Aggregated volume 
           -  Price 
        -------------------------------------------------------  ----------------------------------------------------- 
 
   e)      Date of the transaction                                  2022-10-20 
        -------------------------------------------------------  ----------------------------------------------------- 
 
   f)      Place of the transaction                                 Outside a trading venue 
        -------------------------------------------------------  ----------------------------------------------------- 
 

(e) Professor Tony Mok

 
 1       Details of the person discharging managerial responsibilities/person closely associated 
 
   a)      Name                                                     Professor Tony Mok 
        -------------------------------------------------------  ----------------------------------------------------- 
 2       Reason for the notification 
        -------------------------------------------------------------------------------------------------------------- 
 
   a)      Position/status                                          Independent Non-Executive Director 
        -------------------------------------------------------  ----------------------------------------------------- 
 
   b)      Initial notification/Amendment                           Initial notification 
        -------------------------------------------------------  ----------------------------------------------------- 
 3       Details of the issuer, emission allowance market participant, auction platform, auctioneer 
          or auction monitor 
        -------------------------------------------------------------------------------------------------------------- 
 
   a)      Name                                                     HUTCHMED (China) Limited 
        -------------------------------------------------------  ----------------------------------------------------- 
 
   b)      LEI                                                      2138006X34YDQ6OBYE79 
        -------------------------------------------------------  ----------------------------------------------------- 
 4       Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
          each type of transaction; (iii) each date; and (iv) each place where transactions have been 
          conducted 
        -------------------------------------------------------------------------------------------------------------- 
 
   a)     Description of the financial instrument, type of         ADS each representing five Ordinary Shares of 
          instrument                                               US$0.10 
 
          Identification code 
                                                                   ADS ISIN: US44842L1035 
        -------------------------------------------------------  ----------------------------------------------------- 
 
   b)      Nature of the transaction                               Vesting of awards granted on October 20, 2021 under 
                                                                   HUTCHMED's LTIP 
        -------------------------------------------------------  ----------------------------------------------------- 
                                                                    Price(s)   Volume(s) 
   c)      Price(s) and volume(s)                                    Nil        1,937 ADS 
                                                                               ---------- 
        -------------------------------------------------------  ----------------------------------------------------- 
 
   d)      Aggregated information                                   N/A 
           -  Aggregated volume 
           -  Price 
        -------------------------------------------------------  ----------------------------------------------------- 
 
   e)      Date of the transaction                                  2022-10-20 
        -------------------------------------------------------  ----------------------------------------------------- 
 
   f)      Place of the transaction                                 Outside a trading venue 
        -------------------------------------------------------  ----------------------------------------------------- 
 

About HUTCHMED

HUTCHMED (Nasdaq/AIM: HCM; HKEX: 13) is an innovative, commercial-stage, biopharmaceutical company. It is committed to the discovery and global development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. It has more than 4,900 personnel across all its companies, at the center of which is a team of about 1,800 in oncology/immunology. Since inception it has advanced 13 cancer drug candidates from in-house discovery into clinical studies around the world, with its first three oncology drugs now approved and marketed in China. For more information, please visit: www.hutch-med.com or follow us on LinkedIn.

CONTACTS

 
Investor Enquiries 
  Mark Lee, Senior Vice President        +852 2121 8200 
  Annie Cheng, Vice President            +1 (973) 567 3786 
 
Media Enquiries 
  Americas - Brad Miles, Solebury        +1 (917) 570 7340 (Mobile) | bmiles@soleburystrat.com 
  Europe - Ben Atwell / Alex Shaw, FTI   +44 20 3727 1030 / +44 7771 913 902 (Mobile) / +44 7779 545 055 (Mobile) | 
                                         HUTCHMED@fticonsulting.com 
  Asia - Zhou Yi, Brunswick              +852 97 83 6894 (Mobile) | HUTCHMED@brunswickgroup.com 
 
Nominated Advisor 
  Atholl Tweedie / Freddy Crossley, 
   Panmure Gordon (UK) Limited           +44 (20) 7886 2500 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHURURRUSURUAA

(END) Dow Jones Newswires

October 21, 2022 04:30 ET (08:30 GMT)

1 Year Hutchison China Meditech Chart

1 Year Hutchison China Meditech Chart

1 Month Hutchison China Meditech Chart

1 Month Hutchison China Meditech Chart

Your Recent History

Delayed Upgrade Clock